SNDX Earnings

SNDX reported its FY2025Q3 earnings on 2025-11-03, showcasing a revenue of 45.87M against an estimate of 47.97M, resulting in a -4.38% surprise. The EPS was -0.7, surpassing the expected -0.74 by 5.41%. The stock experienced a 11.56% price change on the earnings day and a 9.3% change over the next five days, reflecting market reactions to the results.

Following SNDX's FY2025Q3 earnings announcement on 2025-11-03, the stock price moved by 11.56% on the day of the release. Over the subsequent five days, it saw a 9.3% change. Historically, SNDX's stock price tends to shift by an average of -3.66% in the 10 days leading up to earnings and -1.97% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate SNDX's annual revenue to reach 70.79M, while the EPS is projected at -0.54. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SNDX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SNDX's stock price typically moves by -3.66% in the 10 days before its earnings and -1.97% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.54 and revenue of 70.79M.

The earnings call summary highlights strong financial performance with revenue and net income growth, a focus on strategic initiatives, and positive market trends in oncology. Although no specific risks were discussed, the company's optimistic outlook on revenue expectations and strategic partnerships suggests a positive sentiment. The market cap of $1.7 billion indicates moderate sensitivity to these factors, leading to a positive prediction for stock movement in the short term.